Naloxone infusion and post-hysterectomy morphine consumption: A double-blind, placebo-controlled study

Acta Anaesthesiologica Scandinavica

Volumn 56, Issue 10, 2012, Pages 1241-1249

  Movafegh, A ^a   Shoeibi, G ^a   Ansari, M ^a   Sadeghi, M ^a   Azimaraghi, O ^a   Aghajani, Y ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; MORPHINE; NALOXONE; PLACEBO; SODIUM CHLORIDE;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG USE; FEMALE; GENERAL ANESTHESIA; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; RECOVERY ROOM; SCORING SYSTEM;

ADULT; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, OPIOID; COUGH; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYSTERECTOMY; INFUSIONS, INTRAVENOUS; MIDDLE AGED; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; PAIN, POSTOPERATIVE; POSTOPERATIVE NAUSEA AND VOMITING; PRURITUS; TREATMENT OUTCOME;

EID: 84867572773     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2012.02764.x     Document Type: Article

References (35)

1. Kehlet H, Wilmore DW,. Multimodal strategies to improve surgical outcome. Am J Surg 2002; 183: 630-641.
2. Kehlet H, Holte H,. Effect of postoperative analgesia on surgical outcome. Br J Anaesth 2001; 87: 62-72.
3. Kehlet H,. Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth 1997; 78: 606-617.
4. Pogatzki-Zahn EM, Zahn K, Brennan Timothy J,. Postoperative pain clinical implications of basic research. Best Pract Res Clin Anaesthesiol 2007; 21: 3-13.
5. Gan TJ, Ginsberg B, Glass PS, Fortney J, Jhaveri R, Perno R,. Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate. Anesthesiology 1997; 87: 1075-1081.
6. Movafegh A, Razazian M, Hajimohamadi F, Meysamie A,. Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesth Analg 2006; 102: 263-267.
7. Sadeghi M, Movafegh A, Nouralishahi B,. The effect of intravenous bolus of ultra- low dose naloxone on intraoperative sedation post-operative pain intensity and morphine consumption in cesarean section patients under spinal anesthesia. Res J Bio Sci 2008; 3: 1223-1228.
8. Ueda H, Fukushima N, Kitao T, Ge M, Tagaki H,. Low doses of naloxone produce analgesia in the mouse brain by blocking presynaptic auto inhibition of encephalin release. Neurosci Lett 1986; 65: 247-5.
9. Levine JD, Gordon NC, Fields HL,. Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain. Nature 1979; 278: 740-741.
10. Miaskowski C, Taiwo YO, Levine JD,. Intracerebroventricular naloxone produces a dose-dependent monotonic increase in nociceptive threshold in the rat. Brain Res 1990; 515: 323-325.
11. Childers SR, Creese I, Snowman AM, Snyder SH,. Opiate receptor binding affected differentially by opiates and opioid peptides. Eur J Pharmacol 1979; 55: 11-18.
12. Crain SM, Shen KF,. Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability. Pain 2000; 84: 121-131.
13. Joshi GP, Duffy L, Chehade J, Wesevich J, Gajraj N, Johnson ER,. Effects of prophylactic nalmefene on the incidence of morphine-related side effects in patients receiving intravenous patient-controlled analgesia. Anesthesiology 1999; 90: 1007-1011.
14. Cepeda MS, Alvarez H, Morales O, Carr DB,. Addition of ultralow dose naloxone to postoperative morphine PCA unchanged analgesia and opioid requirement but decreased incidence of opioid side effects. Pain 2004; 107: 41-46.
15. Maxwell LG, Kaufmann SC, Bitzer S, Jackson EV, McGready J, Kost-Byerly S, Kozlowski L, Rothman SK, Yaster M,. The effects of a small-dose naloxone infusion on opioid-induced side effects and analgesia in children and adolescents treated with intravenous patient-controlled analgesia a double blind prospective randomized controlled study. Anesth Analg 2005; 100: 953-958.
16. Bijur PE, Schechter C, Esses D, Chang AK, Gallagher EJ,. Intravenous bolus of ultra-low-dose naloxone added to morphine does not enhance analgesia in emergency department patients. J Pain 2006; 7: 75-81.
17. Williamson A, Hoggart B,. Pain: a review of three commonly used pain rating scales. J Clin Nurs 2005; 14: 798-804.
18. Phan NQ, Blome C, Fritz F, Gerss J, Reich A, Ebata T, Augustin M, Szepietowski C, Stander S,. Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. Acta Derm Venereol 2011; 92: 502-507.
19. Wengritzky R, Mettho T, Myles PS, Burke J, Kakos A,. Development and validation of a postoperative nausea and vomiting intensity scale. Br J Anaesth 2010; 104: 158-166.
20. Yaster M, Kost-Byerly S, Maxwell LG,. Opioid agonists, and antagonists. In:, Schechter NL, Berde CB, Yaster M, eds. Pain in infants, children, and adolescents. Philadelphia: Lippincott Williams and Wilkins Inc, 2003: 181-225.
21. Watcha MF, White PF,. Postoperative nausea and vomiting its etiology, treatment, and prevention. Anesthesiology 1992; 77: 162-184.
22. Galloway KS, Yaster M,. Pain, and symptom control in terminally ill children. Pediatr Clin North Am 2002; 47: 711-746.
23. Woolf CJ,. Analgesia and hyperalgesia produced in the rat by intrathecal naloxone. Brain Res 1980; 189: 593-597.
24. Levine JD, Gordon NC,. Method of administration determines the effect of naloxone on pain. Brain Res 1986; 365: 377-378.
25. Snyder SH, Pasternak GW,. Historical review: opioid receptors. Trends Pharmacol Sci 2003; 24: 198-205.
26. Standifer KM, Pasternak GW,. G proteins and opioid receptor mediated signaling. Cell Signal 1997; 9: 237-248.
27. Nestler EJ, Hyman SE, Malenka RC,. Pain. In:, Nestler EJ, Hyman SE, Malenka RC, eds. Molecular neuropharmacology: a foundation for clinical neuroscience. New York: McGraw-Hill Companies Inc., 2001: 433-452.
28. Tsai RY, Tai YH, Tzeng JI, Lin SL, Shen CH, Yang CP, Hsin ST, Wang CB, Wong CS,. Ultra-low dose naloxone restores the anti-nociceptive effect of morphine in pertussis toxin-treated rats and prevents glutamate transporter down-regulation by suppressing the p38 mitogen-activated protein kinase signaling pathway. Neuroscience 2009; 159: 1244-1256.
29. Yang CP, Cherng CH, Wu CT, Huang HY, Tao PL, Wong CS,. Intrathecal ultra-low dose naloxone enhances the anti-nociceptive effect of morphine by enhancing the reuptake of excitatory amino acids from the synaptic cleft in the spinal cord of partial sciatic nerve-transected rats. Anesth Analg 2011; 113: 1490-1500.
30. Crain SM, Shen KF,. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia. Brain Res 2001; 888: 75-82.
31. Crain SM, Shen KF,. Modulation of opioid analgesia, tolerance, and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions. Trends Pharmacol Sci 1998; 19: 358-365.
32. Parker RK, Holtmann B, White PF,. Patient-controlled analgesia. Does a concurrent opioid infusion improve pain management after surgery? JAMA 1991; 266: 1947-1952.
33. Cepeda MS, Africano JM, Manrique AM, Fragoso W, Carr DB,. The combination of low dose of naloxone and morphine in PCA does not decrease opioid requirements in the postoperative period. Pain 2002; 96: 73-79.
34. Sartain JB, Barry JJ, Richardson CA, Branagan HC,. Effect of combining naloxone and morphine for intravenous patient controlled analgesia. Anesthesiology 2003; 99: 148-151.
35. Doyle E, Robinson D, Morton NS,. Comparison of patient controlled analgesia with and without a background infusion after lower abdominal surgery in children. Br J Anaesth 1993; 71: 670-673.